Riskpilot← Back to searchSign inGet full accessGustafkliniken AB
ABActiveOrg 5593026882Lejonstigen 2General medical practice activities · NACE 8621Est. 202120-49 employees
Revenue 2024
SEK 12M
+129% vs 2023
EBITDA margin
-10.3%
+81% vs 2023
Equity ratio
23.9%
Financial strength
Net profit 2024
SEK -1,5M
+79% vs 2023
| Revenue | SEK 12M | +129% |
| EBITDA | SEK -1,2M | +81% |
| Net profit | SEK -1,5M | +79% |
| Total assets | SEK 3M | +21% |
| Equity | SEK 719K | +126% |
| Employees | — | — |
Legal name
Gustafkliniken AB
Org number
5593026882
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 februari 2021
Share capital
SEK 25 000
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Almesjö, Per Staffan Albert Varre Almesjö, Anne Therese
Company purpose
Vårdbolag inom primärvård.
Address
Lejonstigen 2
Email
admin@gustafkliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 14 583 | 0 | 5 230 | 11 983 |
| Staff expenses | — | −155 | −5 207 | −9 584 |
| EBITDA | 3 952 | −1 266 | −6 691 | −1 238 |
| Depreciation & amort. | −11 | −84 | −107 | −108 |
| EBIT | 3 941 | −1 349 | −6 798 | −1 346 |
| Net financials | −13 | −42 | −114 | −108 |
| Profit before tax | 2 932 | −513 | −6 912 | −1 454 |
| Tax | −605 | — | — | — |
| Net profit | 2 327 | −513 | −6 912 | −1 454 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 6 625 | 3 589 | 2 499 | 3 013 |
| Equity | 2 352 | 1 481 | 318 | 719 |
| Long-term debt | 117 | 1 050 | 1 033 | 833 |
| Short-term debt | 3 160 | 1 058 | 1 147 | 1 460 |
| Total debt | 3 277 | 2 108 | 2 180 | 2 293 |
EBITDA margin
-10.3%
This company
15.8%
Market median
-165% vs market
20212024
Equity ratio
23.9%
This company
38.2%
Market median
-37% vs market
20212024
Return on equity
-202.1%
This company
18.4%
Market median
-1198% vs market
20212024
Net profit margin
-12.1%
This company
8.1%
Market median
-249% vs market
20212024
Asset turnover
3.98×
This company
1.12×
Market median
+255% vs market
20212024
Debt / equity
3.19×
This company
0.62×
Market median
-415% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
KL Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2025 |
SM Audit | Audit | 2025 |
AT Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gustafkliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| K Louise G C von Stockenström | Deputy Chief Executive Officer | 0 companies |
| Sven Magnus Wennlöf | Audit | 0 companies |
| Anne Therese Varre Almesjö | Chief Executive Officer | 0 companies |
| Per Staffan Albert Almesjö | Chairman | 0 companies |
| Björn Nils Ola Sellert | Board of Directors | 0 companies |